Literature DB >> 4825614

Adrenal cortical degeneration and regeneration following administration of DDD.

J M Powers, G R Hennigar, G Grooms, J Nichols.   

Abstract

Degeneration and regeneration of canine adrenal cortical cells following DDD administration are described. The degenerative phase is rapid in onset and dose related. It is morphologically characterized by profound cytoplasmic vacuolation due to severe mitochondrial damage, disruption of the smooth endoplasmic reticulum, autolysosomal response and lipid accumulation. Toxic necrosis with a mononuclear cell reaction and fibrosis also occurs. The regenerative phase consists of centripetal cellular regeneration, cellular repair and some residual damage. Several of the ultrastructural and biochemical findings are discussed in relation to the pertinent literature.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4825614      PMCID: PMC1910812     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  10 in total

1.  SPECIFICITY OF ENZYME INHIBITION BY DDD.

Authors:  H J GRADY; D L AZARNOFF; R CREAGAR; D H HUFFMAN; J NICHOLS
Journal:  Proc Soc Exp Biol Med       Date:  1965-05

2.  Action of 1,1,dichloro-2-p-chlorophenyl-2-o-chlorophenylethane on dog adrenal cortex.

Authors:  A CAZORLA; F MONCLOA
Journal:  Science       Date:  1962-04-06       Impact factor: 47.728

3.  Effects of o,p' DDD on histology and 17-hydroxycorticosteroid output of the dog adrenal cortex.

Authors:  O VILAR; W W TULLNER
Journal:  Endocrinology       Date:  1959-07       Impact factor: 4.736

4.  Ultrastructure of adrenal cortex of the dog during treatment with DDD.

Authors:  N KAMINSKY; S LUSE; P HARTROFT
Journal:  J Natl Cancer Inst       Date:  1962-07       Impact factor: 13.506

5.  The effect of isomers of DDD on the ACTH-induced steroid output, histology and ultrastructure of the dog adrenal cortex.

Authors:  M M Hart; R L Reagan; R H Adamson
Journal:  Toxicol Appl Pharmacol       Date:  1973-01       Impact factor: 4.219

6.  Studies on the site of action of o,p'-DDD in the dog adrenal cortex. 1. Inhibition of ACTH-mediated pregnenolone synthesis.

Authors:  M M Hart; J A Straw
Journal:  Steroids       Date:  1971-05       Impact factor: 2.668

7.  Studies on the site of action of o,p'-DDD in the dog adrenal cortex. II. TPNH- and corticosteroid precursor-stimulation of o,p'-DDD inhibited steroidogenesis.

Authors:  M M Hart; E S Swackhamer; J A Straw
Journal:  Steroids       Date:  1971-05       Impact factor: 2.668

8.  The effect of o,p'DDD on cortisol and hexobarbital metabolism.

Authors:  D Kupfer; L Peets
Journal:  Biochem Pharmacol       Date:  1966-05       Impact factor: 5.858

9.  The ultrastructure of the normal dog adrenal.

Authors:  J M Bloodworth; K L Wers
Journal:  J Anat       Date:  1968-03       Impact factor: 2.610

10.  Studies on DDD, 2,2-bis (parachlorophenyl)-1,1-dichloroethane.

Authors:  J NICHOLS; G HENNIGAR
Journal:  Exp Med Surg       Date:  1957
  10 in total
  3 in total

1.  Adrenocorticolytic DDT-metabolites: studies in mink, Mustela vison and otter, Lutra lutra.

Authors:  C J Jönsson; B O Lund; I Brandt
Journal:  Ecotoxicology       Date:  1993-03       Impact factor: 2.823

2.  Hyperadrenocorticism in dogs: a study of eight cases.

Authors:  J G Spearman; P B Little
Journal:  Can Vet J       Date:  1978-02       Impact factor: 1.008

3.  Adreno-leukodystrophy (sex-linked Schilder's disease). A pathogenetic hypothesis based on ultrastructural lesions in adrenal cortex, peripheral nerve and testis.

Authors:  J M Powers; H H Schaumburg
Journal:  Am J Pathol       Date:  1974-09       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.